Bio-Rad Laboratories Inc (BIO)vsEdwards Lifesciences Corp (EW)
BIO
Bio-Rad Laboratories Inc
$264.49
-0.19%
HEALTHCARE · Cap: $7.14B
EW
Edwards Lifesciences Corp
$82.50
+0.05%
HEALTHCARE · Cap: $47.92B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 135% more annual revenue ($6.07B vs $2.58B). BIO leads profitability with a 29.4% profit margin vs 17.7%. BIO appears more attractively valued with a PEG of 1.19. BIO earns a higher WallStSmart Score of 60/100 (C).
BIO
Buy60
out of 100
Grade: C
EW
Buy55
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-55.1%
Fair Value
$189.38
Current Price
$264.49
$75.11 premium
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.50
$70.19 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Keeps 29 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Strong operational efficiency at 23.7%
Areas to Watch
3.9% revenue growth
Weak financial health signals
Earnings declined 83.0%
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : BIO
The strongest argument for BIO centers on P/E Ratio, Price/Book, Altman Z-Score. Profitability is solid with margins at 29.4% and operating margin at 8.9%. PEG of 1.19 suggests the stock is reasonably priced for its growth.
Bull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bear Case : BIO
The primary concerns for BIO are Revenue Growth, Piotroski F-Score, EPS Growth.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.6x leaves little room for execution misses.
Key Dynamics to Monitor
BIO profiles as a value stock while EW is a mature play — different risk/reward profiles.
BIO carries more volatility with a beta of 1.20 — expect wider price swings.
EW is growing revenue faster at 13.3% — sustainability is the question.
EW generates stronger free cash flow (354M), providing more financial flexibility.
Bottom Line
BIO scores higher overall (60/100 vs 55/100), backed by strong 29.4% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Bio-Rad Laboratories Inc
HEALTHCARE · MEDICAL DEVICES · USA
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
Visit Website →Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?